Irene Aquino

Irene Aquino is a seasoned professional in patient advocacy with extensive experience in the biopharmaceutical industry. Currently serving as Senior Director of Patient Advocacy at Sionna Therapeutics since August 2025, Irene previously held the position of Global Head of Patient and Professional Advocacy at Amylyx Pharmaceuticals, where influential contributions to the ALS advocacy strategy aided in the successful FDA approval of RELYVRIO. Irene's prior roles include Vice President of Patient Advocacy at Rhythm Pharmaceuticals, where a global engagement function for rare genetic disorders of obesity was established, and Vice President at Alnylam Pharmaceuticals, leading the development of a global patient advocacy team. Irene's career spans positions with Biogen, Shire HGT, EMD Serono, and sanofi-aventis, demonstrating a strong commitment to enhancing patient engagement and advocacy across various therapeutic areas. Irene holds a Bachelor of Science degree in Speech Pathology and Audiology from the University of Hawaii at Manoa.